Robert C. Brunham is the head of the Vaccine Research Laboratory at BCCDC and a professor of medicine at UBC. Until 2014, he was also the executive and scientific director of BCCDC.
Dr. Brunham's research is in the field of immunology and the epidemiology of sexually transmitted diseases. His research focuses on developing a vaccine for chlamydia trachomatis.
Recently, in collaboration with UBC scientists, he pioneered a cutting edge proteomic approach to chlamydia vaccine development which has generated international interest and financial support from the National Institutes of Health.Bio
Dr. Brunham holds a University of Washington post-doctoral fellowship in infectious disease and has a medical degree from UBC.
He has received international recognition and awards for his contributions to the field of infectious diseases prevention. He was the 2004 recipient of the prestigious Thomas Parran Award from the American Sexually Transmitted Disease Association for his long and distinguished contributions in research and was the 2005 co-recipient of the CIHR Partnership Award for his co-leadership in the SARS Accelerated Vaccine Initiative.
- For Dr. Brunham's publications, see PubMed.
- For citations of Dr. Brunham's publications, see Google Scholar.